|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Design Therapeutics (NASDAQ: DSGN) through any online brokerage.
There are no as such competitors for Design Therapeutics.
The latest price target for Design Therapeutics (NASDAQ: DSGN) was reported by SVB Leerink on April 20, 2021. The analyst firm set a price target for 36.00 expecting DSGN to rise to within 12 months (a possible 54.97% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Design Therapeutics (NASDAQ: DSGN) is $23.23 last updated Tue Jun 22 2021 20:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Design Therapeutics.
There is no upcoming split for Design Therapeutics.
Design Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.